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Abstract
Local excision of hilar cholangiocarcinomas results in long-term survival in only very few cases. Therefore, the combination
of right or left liver resection and bile duct resection has been the standard treatment since about 1990. Five-year survival
rates after curative resection could be improved to 3040%. Recurrence is frequently seen locally, therefore more extended
resection with adherence to the surgical principals of tumor resection, such as the ‘‘no-touch technique’’, appears useful.
Excellent results with 5-year survival rates up to 60% after curative resection can be achieved with right trisectionectomy
together with principle en bloc hilar resection. Perioperative mortality is still high because of the small remaining liver
volume.
It is now more than 40 years since the first reports of
surgery for hilar cholangiocarcinoma, but generally
accepted guidelines for the strategy of radical resec-
tions are still lacking for this disease [1,2]. One major
reason for this shortcoming may be the lack of
randomized trials regarding the efficacy of the differ-
ent surgical strategies, implementation of which is
clearly aggravated by the rareness of the tumor.
Therefore, our current knowledge about results of
radical surgery for hilar cholangiocarcinoma is mainly
based on the findings of observational studies.
First reports of larger series in the 1970s and 1980s
reported long-term survival in some patients and
improved overall survival figures after surgical resec-
tion [35]. Based on the results of such studies,
surgery as the only curative approach in hilar cholan-
giocarcinoma became the treatment of choice in
suitable patients. However, with local excisions,
including resection of the supraduodenal bile duct,
cholecystectomy and portal lymphadenectomy with
restoration of the bilioenteric continuity, curative
resections were only achieved in a minority of patients
and cure was rarely observed [6,7]. Recurrence
occurred frequently after such local excisions even
after the curative nature of the procedure, with the
liver hilum as the most frequent site of recurrence [8].
Histomorphological analysis of tumor specimens and
clinical experience with the cancer revealed that hilar
cholangiocarcinoma did not seem to metastasize as
early and frequently as other gastrointestinal cancers,
but perineural invasion and lymphangiosis carcino-
matosa, which can extend up to two centimeters from
the tumor into the liver and distally into the hepato-
duodenal ligament were described frequently [911].
Therefore, the tumor cannot be radically resected by
local excisions and today only exceptionally is hilar
resection considered curative treatment in patients
with hilar cholangiocarcinoma. Since the bile duct of
the caudate lobe comes frequently as a direct branch
from the bile duct bifurcation, it was thought that
additional resection of the caudate lobe would sig-
nificantly improve the survival rates after surgical
resection [12]. However, no survival advantage of
additional caudate lobe resection has been documen-
ted so far.
As hilar cholangiocarcinoma extends centimeters
behind its visible and palpable extensions, broadening
of the tumor-free resection margins was considered to
be crucial for the results after surgical resection.
Owing to its anatomical location, the liver is in close
contact with the tumor and direct infiltration is
described frequently [13]. Therefore, an additional
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resection of the right or left liver lobe is considered
to be essential for a radical surgical approach. With
the additional liver resection it is possible to get wide
resection margins at the proximal ramification of
the tumor and to resect eventual tumor infiltrations
of the parenchyma as well. Most centers have adopted
this approach over the past two decades and the
results have clearly improved compared to hilar
resection alone. Reported curative resection rates are
around 70%, with long-term survival between 20%
and 40% [1420]. The results of selected observa-
tional studies are depicted in Figure 1. Based on these
observational studies of most of the hepatobiliary
centers worldwide, hilar resection with additional
major hepatectomy is currently accepted as the
treatment of choice for hilar cholangiocarcinoma in
suitable patients.
The type and extent of the additional liver resection
are still controversial, however. The efficacy of addi-
tional liver resection has been demonstrated in
multiple series, although significant differences in
long-term results after different types of liver resec-
tions have been much less reported. In a prospective
study on 40 patients, Kondo et al. found a significant
survival advantage for patients who underwent right
hemihepatectomy [21]. Compared to left lobe resec-
tion, the advantage probably comes from less exten-
sive preparation during the right-sided lobectomy,
since the biliary confluence lies on the right side of the
hepatic hilum. Moreover, the right hepatic artery runs
close to the bile duct bifurcation and does not have to
be separated from the tumor during right-sided
lobectomy, which probably leads to an increase in
radicality.
We described a right trisectionectomy with en bloc
portal vein and bile duct resection as an independent
prognostic factor for survival after curative resection
[19]. The advantage of this procedure compared to
major liver resection alone is probably due to in-
creased radicality, because the right branch of the
portal vein is in close contact with the tumor and is
frequently infiltrated by the tumor. The right hepatic
artery runs between the tumor and portal vein and is
also often infiltrated, whereas the left artery runs on
the left margin of the hepatoduodenal ligament and is
almost never attached to the tumor. En bloc resection
of extrahepatic bile ducts, portal vein bifurcation, and
right hepatic artery, together with six liver segments I
and VI to VIII is a principle advantage in oncological
surgery, because only this technique follows the
oncological rules of a ‘‘no-touch technique’’ [22].
Taken together, the oncological principles of wide
tumor-free resection margins, the avoidance of dis-
section near tumor tissue (no-touch technique) and
the principle use of right trisectionectomy not only
yield better results, but also allow for increased
resectability. If the left lateral lobe of the liver on the
other hand is too small or the portal vein of the left
side is infiltrated by a tumor, as in Bismuth type VI
cases, an extended left hepatectomy together with
resection of the biliary system as far to the right side as
possible is the second best choice. Here, dissection of
the right hepatic artery and portal vein cannot be
avoided, but with an R0 resection a 30% 5-year
survival may still be achieved.
Right trisectionectomy, together with en bloc hilar
resection, allows for encouraging long-term results
with 5-year survival rates up to 60% after curative
resection [19], but the postoperative mortality has to
be taken into account. Hepatic failure is the most
frequent cause of postoperative deaths after such
extensive liver resections. Therefore, besides careful
patient selection, a preoperative multimodal treat-
ment approach is needed to optimize the remnant
liver function. Such a multimodal approach includes
recovery of damaged liver function and treatment of
segmental cholangitis by sufficient biliary decompres-
sion and hypertrophy of and functional transition to
the future remnant liver by portal embolization
[23,24].
Consensus statements
. Currently, hilar resection with additional major
liver resection is the treatment of choice in
suitable patients with right-sided hilar cholangio-
carcinoma (low; multiple observational studies).
. Right-sided hemihepatectomy and extended
right-sided hemihepatectomy are the preferred
procedures for additional liver resection (low, few
observational studies).
Figure 1. Schematic image of the hepatic hilum. The confluence of
the right and left hepatic bile ducts is located on the right side of the
hepatoduodenal ligament. The right hepatic artery runs on the
dorsal side close to the common bile duct. The area of the hepatic
hilum that can be approached without dissecting hepatic parench-
yma is encircled by the continuous line [25].
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. The best results seem to be achieved by en bloc
right trisectionectomy and portal vein resection
(low, one observational study).
. Hilar resection is currently considered a palliative
procedure in these patients (low, multiple ob-
servational studies).
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